Stock data
Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks Holdings, Inc. (DNA) reported revenue of US$170.16M and net income of -US$312.76M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$170.16M | — | -US$315.28M | -US$312.76M | — |
| 2024 | US$227.04M | — | -US$559.76M | -US$547.03M | — |
| 2023 | US$251.46M | — | -US$864.41M | -US$892.87M | — |
| 2022 | US$477.71M | — | -US$2.21B | -US$2.10B | — |
| 2021 | US$313.84M | — | -US$1.83B | -US$1.83B | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$20.16M | -US$46.71M | — |
| 2026-03-31 | US$19.47M | -US$82.59M | — |
| 2025-12-31 | US$53.95M | -US$80.75M | — |
| 2025-09-30 | US$38.84M | -US$80.75M | — |
| 2025-06-30 | US$39.13M | -US$60.30M | — |
| 2025-03-31 | US$38.23M | -US$90.96M | — |
| 2024-12-31 | US$43.85M | -US$107.53M | — |
| 2024-09-30 | US$89.05M | -US$56.40M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.